Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes

Diabetes Care

Volumn 32, Issue 7, 2009, Pages 1137-1142

  Kazempour Ardebili, Sara ^a   Lecamwasam, Varunika L ^b   Dassanyake, Thushara ^b   Frankel, Andrew H ^b   Tam, Frederick W K ^b   Dornhorst, Anne ^a   Frost, Gary ^a   Turner, Jeremy J O ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLICLAZIDE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ASPART; INSULIN GLARGINE; ISOPHANE INSULIN;

ADULT; AGED; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HEMODIALYSIS PATIENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS; HOMEOSTASIS; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PATIENT SELECTION; RENAL DIALYSIS;

EID: 67650072969     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1688     Document Type: Article

References (27)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047
2. United States Renal Data System. USRDS 2007 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States [article online], 2007. Available from http://www.usrds.org/adr.htm. Accessed 12 September 2008
3. Hakim RM, Levin N. Malnutrition in hemodialysis patients. Am J Kidney Dis 1993;21:125-137
4. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007;49:S12-S154
5. American Diabetes Association. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 2002;25:S28-S32
6. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653
7. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
8. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572
9. Cano NJ, Roth H, Aparicio M, Azar R, Canaud B, Chauveau P, Combe C, Fouque D, Laville M, Leverve XM. Malnutrition in hemodialysis diabetic patients: evaluation and prognostic influence. Kidney Int 2002;62:593-601
10. American Diabetes Association. Intense blood glucose control yields no significant effect on CVD reduction in VA Diabetes Trial [article online], 2008. Available from http://www.diabetes.org/for-media/pr-intense-blood-glucose- control-yields-no-significant-effecton-cvd-reduction.jsp. Accessed 12 September 2008
11. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
12. NICE, National Institute of Health and Clinical Excellence. Clinical guidelines for the management of type 2 diabetes [article online], 2008. Available from http://www.nice.org.uk/CG66. Accessed on 12 September 2008
13. American Diabetes Association. Standards of medical care in diabetes - 2007. Diabetes Care 2007;30:S4-S41
14. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial. Diabetes Care 2002;25:275-278
15. Little RR, Tennill AL, Rohlfing C, Wiedmyere HM, Khanna R, Goel S, Agrawal A, Madsen R, Goldstein DE. Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure? Clin Chem 2002;48:784-786
16. Nissenson AR, Fine RN: Dialysis Therapy. 3rd ed. Philadelphia, Hanley & Belfus, 2002
17. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001;47:153-163
18. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, DiMario U, Annuzzi G, Genovese S, Ricardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002;25:347-352
19. Nelson M, Atkinson M, Meyer J, Nutritional Epidemiology Group UK. Food Portion Sizes: A Photographic Atlas. London, MAFF Publications, 1997
20. Renal Association. Treatment of Adults and Children with Renal Failure: Standards and Audit Measures. 3rd ed. London, Royal College of Physicians of London and the Renal Association, 2002
21. Takahashi A, Kubota T, Shibahara N, Terasaki J, Kagitani M, Ueda H, Inoue T, Katsuoka Y. The mechanism of hypoglycemia caused by hemodialysis. Clin Nephrol 2004;62:362-368
22. Williams ME, Lacson E Jr, Teng M, Ofsthun N, Lazarus JM. Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival. Kidney Int 2006;70:1503-1509
23. Oomichi T, Emoto M, Tabata T, Morioka T, Tsujimoto Y, Tahara H, Shoji T, Nishizawa Y. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care 2006;29:1496-1500
24. Lee KF, Szeto YT, Benzie IF. Glycohaemoglobin measurement: methodological differences in relation to interference by urea. Acta Diabetol 2002;39:35-39
25. Schnedl WJ, Lahousen T, Wallner SJ, Krause R, Lipp RW. Silent hemoglobin variants and determination of HbA1c with the high-resolution program of the HPLC HA-8160 hemoglobin analyzer. Clin Biochem 2005;38:88-91
26. Joy MS, Cefalu WT, Hogan SL, Nachman PH. Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis 2002;39:297-307
27. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ, A1c-Derived Average Glucose Study Group: Translating the A1c assay into estimated average glucose values. Diabetes Care 2008;31:1473-1478